La bourse ferme dans 3 h 38 min

IQVIA Holdings Inc. (IQV)

NYSE - NYSE Prix différé. Devise en USD
Ajouter à la liste dynamique
229,60+2,51 (+1,11 %)
À la clôture : 04:00PM EDT
229,60 0,00 (0,00 %)
Avant Bourse : 07:09AM EDT

IQVIA Holdings Inc.

2400 Ellis Road
Durham, NC 27703
United States
919 998 2000
https://www.iqvia.com

Secteur(s)Healthcare
Secteur d’activitéDiagnostics & Research
Employés à temps plein87 000

Dirigeants clés

NomTitrePayerExercéAnnée de naissance
Mr. Ari BousbibCEO & Chairman7,15MS.O.1961
Mr. Ronald E. BruehlmanExecutive VP & CFO2,14MS.O.1961
Mr. Eric M. SherbetExecutive VP, General Counsel & Secretary1,37MS.O.1964
Mr. W. Richard Staub IIIPresident of Research & Development Solutions886,44k3,59M1963
Ms. Keriann CherofskySenior VP, Corporate Controller & Chief Accounting OfficerS.O.S.O.1985
Mr. Jim BerkshireExecutive Vice President of Global Technology & OperationsS.O.S.O.S.O.
Dr. Jeffrey A. Spaeder M.D.Senior VP, Global Chief Medical & Scientific OfficerS.O.S.O.S.O.
Kerri JosephSVP of Investment Relation & TreasuryS.O.S.O.S.O.
Ms. Trudy SteinChief Human Resources Officer & Executive VPS.O.S.O.S.O.
Dr. Cynthia L. VerstPresident of Design & Delivery InnovationS.O.S.O.S.O.
Les montants ont été établis en date du 31 décembre 2023 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en USD.

Description

IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a collaboration with argenx SE. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is headquartered in Durham, North Carolina.

Gouvernance d’entreprise

L’ISS Governance QualityScore de IQVIA Holdings Inc. en date du 1 mai 2024 est 8. Les scores principaux sont Audit : 5; Société : 8; Droits des actionnaires : 7; Compensation : 8.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.